Thursday, August 15, 2019 8:44:09 AM
Why I own TLT stock.
[NOTE: new member.. Let me know if I break any rules.]
I found and bought TLT because I have cancer. I stumbled upon the company while researching my disease, not while searching for a stock to buy. I don't know much about investing. Perhaps I'm a fool.
I prayed this Phase II would start sooner, but alas I lost my bladder in March--missed by a few months. Today I have a bag hanging by tape off the side of my stomach. Patients #5 and #6 must feel like the luckiest humans alive--and they are.
As I said above, I don't know much about investing, but I'm a 16 year NMIMBC veteran, having endured 20+ BCG treatments before I could no longer tolerate them.
Then I heard there is a company working on a 'cure' that uses only 1 or 2 threatments? and its with a drug that is not toxic? (I had to pour clorox in my toilet after each BCG treatment. and I lost 2 days a week from BCG side effects like nausea, fever, chills, etc.)
Every current bladder cancer patient will scream for this treatment--even if it not as effective as BCG--should it ever become approved. It's a double winner: it 'cures' cancer, and its much easier treatment regime.
Multiply your wildest $$$ projections by 10, folks. Patients will demand this treatment over the agony of BCG. IMHO it will vanquish BCG. Big pharma will be very sad. Sell those shares now.
[NOTE: new member.. Let me know if I break any rules.]
I found and bought TLT because I have cancer. I stumbled upon the company while researching my disease, not while searching for a stock to buy. I don't know much about investing. Perhaps I'm a fool.
I prayed this Phase II would start sooner, but alas I lost my bladder in March--missed by a few months. Today I have a bag hanging by tape off the side of my stomach. Patients #5 and #6 must feel like the luckiest humans alive--and they are.
As I said above, I don't know much about investing, but I'm a 16 year NMIMBC veteran, having endured 20+ BCG treatments before I could no longer tolerate them.
Then I heard there is a company working on a 'cure' that uses only 1 or 2 threatments? and its with a drug that is not toxic? (I had to pour clorox in my toilet after each BCG treatment. and I lost 2 days a week from BCG side effects like nausea, fever, chills, etc.)
Every current bladder cancer patient will scream for this treatment--even if it not as effective as BCG--should it ever become approved. It's a double winner: it 'cures' cancer, and its much easier treatment regime.
Multiply your wildest $$$ projections by 10, folks. Patients will demand this treatment over the agony of BCG. IMHO it will vanquish BCG. Big pharma will be very sad. Sell those shares now.
Recent TLTFF News
- Theralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update • Newsfile • 05/04/2026 09:22:00 PM
- Theralase(R) Closes $CAN 2.66 Million Financing • Newsfile • 04/10/2026 11:00:00 AM
- Theralase(R) Closes $1.1 M Non-Brokered Private Placement • Newsfile • 03/10/2026 11:00:00 AM
- Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer • Newsfile • 03/09/2026 11:00:00 AM
- Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/20/2026 12:00:00 PM
- Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress • Newsfile • 02/17/2026 12:00:00 PM
- Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting • Newsfile • 02/10/2026 12:00:00 PM
- Theralase(R) Provides Update on Bladder Cancer Clinical Study • Newsfile • 02/04/2026 12:00:00 PM
- Theralase and Ferring ink deal for new bladder cancer study • IH Market News • 01/14/2026 11:05:00 AM
- New Bladder Cancer Collaboration Sparks Sharp Rally in This Micro Cap Stock • AllPennyStocks.com • 01/12/2026 03:23:00 PM
- Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer • Newsfile • 01/12/2026 12:00:00 PM
- Theralase(R) Closes $1.3 M Non-Brokered Private Placement • Newsfile • 12/23/2025 09:40:00 PM
- Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing • Newsfile • 12/12/2025 10:00:00 PM
- Theralase(R) Investor Conference Call Reminder • Newsfile • 11/17/2025 12:00:00 PM
- Theralase(R) Releases 3Q2025 Financial Statements • Newsfile • 11/10/2025 12:00:00 PM
- Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus • Newsfile • 09/24/2025 11:00:00 AM
